Michelle Linterman interviewed on her important COVID-19 research in mice by Cambridge Independent editor Paul Brackley.
Michelle Linterman talks to Medicine Maker reporter Stephanie Sutton about her drug repurposing findings.
Tumor Biology Study Suggests Promising New Route to Cancer Drug Development